Farms.com Home   News

H1N1 and H1N2 Viruses Represent Low Risk to People

The General Manger of Manitoba Pork says the identification of two rare strains of Influenza virus in humans in Manitoba poses a minimal risk to humans. On Friday Manitoba's Chief Public Health Officer and Chief Veterinary Officer confirmed two positive human cases, one of H1N1 and one of H1N2 virus and that the cases are unrelated.

Cam Dahl, the General Manager of Manitoba Pork, notes although these strains are reportable to the Public Health Agency of Canada and the World Health Organization, they represent a low-risk people.

Clip-Cam Dahl-Manitoba Pork:

These are variations of the Influenza A virus and these two strains in particular are really quite rare in people. The H1N2 variant, there's only been 29 cases in the world since we started monitoring in 2005 and the H1N1 variant that was found, there's only been two cases ever found in Canada.

These are two very rare strains of Influenza and there's very low risk as was announced by the CVO and the Chief Public Health Officer on Friday. There's very low risk of transmissibility between people.

In fact, we have no evidence of sustained transmissibility between people so there's very low risk to the public and fortunately the two people that did contract these strains of  the flu, their symptoms were very mild and they have both recovered so there's really very little risk to the Manitoba population.

Source : Farmscape

Trending Video

New Solution Powers Efficient Pork Growth

Video: New Solution Powers Efficient Pork Growth


Alltech has introduced Olerix, an innovative phytogenic blend created to promote growth and feed efficiency in pigs. Through a proprietary coating process, the bioactive blend of phytogenic compounds used in Olerix is designed to outlast the manufacturing process, ensuring consistent outcomes from feed to finish. The result is a high-impact efficiency solution that provides consistent support for gut health, feed efficiency, immune function and growth performance. Olerix is backed by validated trials conducted under modern pork production conditions.

“As the industry searches for technology to drive profitability forward in a more sustainable manner, we’re thrilled to join that effort with our Olerix technology,” said Mark Hulsebus, general manager for U.S. pork at Alltech. “Our work in this phytogenic space is yielding very encouraging results, and we’re excited to make this new opportunity available to pork producers focused on optimizing feed efficiency and growth rates.”

“Olerix represents the next generation of phytogenic technology — combining feed efficiency, livability and immune support into a practical commercial solution producers can implement today,” said Andy Rash, U.S. monogastric director at Alltech.